Coronavirus India South Africa virus vaccine strain Coronavirus India South Africa

SII may have to adjust Covid vaccine composition for South African variant

Reading now: 188

Serum Institute of India (SII) may have to adjust the composition of AstraZeneca/Oxford vaccine that it is manufacturing, after the World Health Organisation’s (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) on Monday and Tuesday showed concern over effectiveness of the vaccine against South African mutant coronavirus strain.The SAGE was reviewing the evidence on the vaccine’s effectiveness on new virus SARS CoV-2 variants and made significant recommendations in the backdrop of the decision of South Africa to halt the rollout of the Oxford-AstraZeneca vaccine after preliminary clinical trial findings of a study published by the Wits Vaccines and Infectious Diseases Analytics Research Unit indicated the vaccine offered.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News